A. Left Suprapubic Skin, Biopsy by Shave Method Invasive Malignant Melanoma. COMMENT: Tumor (Breslow) thickness: 0.8...

TL;DR: You have early-stage melanoma (stage 1B) that was caught at a thickness of 0.8 mm with clear deep margins, which is good news for treatment and outcomes — but you'll need a wider surgical excision and close follow-up.

---

KEY POINTS:

• Breslow thickness of 0.8 mm puts you in stage 1B — this is early-stage melanoma, and early detection significantly improves outcomes
• Deep margin is clear (less than 1 mm away) — this means the surgeon got good clearance at the base, reducing recurrence risk
• Peripheral margin involved by in situ component — you'll need a wider excision surgery to remove the surrounding area where pre-cancerous cells were found
• No aggressive features present — zero mitotic rate, no ulceration, no lymphovascular invasion, and no neurotropism are all favorable prognostic signs
• Sentinel lymph node biopsy (SLNB) is likely recommended — because you're stage 1B, your doctor will probably want to check if cancer has spread to nearby lymph nodes

---

NEXT STEP:

Schedule a follow-up appointment with your dermatologist or surgical oncologist to discuss wide excision surgery and sentinel lymph node biopsy timing.

---

[[FULL_ANSWER]]

What Your Pathology Report Shows

Your biopsy confirms invasive malignant melanoma — a serious form of skin cancer that started in melanocytes (pigment-producing cells in your skin). The good news is that it was caught early, and several features of your tumor are favorable.

---

Breaking Down the Key Measurements

Breslow Thickness (0.8 mm)

This measures how deep the melanoma has grown into your skin layers, measured in millimeters. Your thickness of 0.8 mm is relatively thin. According to the NCCN Guidelines for Patients: Melanoma, Breslow thickness is one of the most important predictors of melanoma stage and treatment decisions.

For context: the tip of a pencil is about 1 mm thick, so your tumor is slightly less than that.

Clark Level IV

This describes which layer of skin the cancer has invaded. Clark Level IV means the melanoma has reached the dermis (the second, deeper layer of skin). This is why it's classified as "invasive" — it has broken through the top layer (epidermis) into deeper tissue. This is expected for a melanoma of this thickness.

Pathologic Stage: pT1b

Your stage is pT1b, which translates to Stage 1B melanoma. According to NCCN Guidelines, Stage 1B melanoma includes tumors that are:

• Between 0.8 mm and 1 mm thick, OR
• Less than 0.8 mm thick WITH ulceration (broken skin)

Your tumor is 0.8 mm without ulceration, placing you at the boundary of 1A/1B. The presence of the in situ component (see below) and other factors likely moved you to 1B classification.

---

Favorable Prognostic Features (Good Signs)

Your pathology report contains several features that suggest a better outlook:

No Ulceration

• Ulceration (a breakdown or open sore on top of the melanoma) is a sign of more aggressive disease
• Your report shows ulceration was "not identified" — this is favorable
• According to NCCN Guidelines, non-ulcerated melanomas have lower risk of spreading

Zero Dermal Mitotic Rate

• The dermal mitotic rate (DMR) measures how fast cancer cells are dividing
• A count of zero means no dividing cells were seen under the microscope
• According to NCCN Guidelines, higher mitotic rates indicate greater likelihood of spread; yours is the best possible score

No Lymphovascular or Angiolymphatic Invasion

• This means cancer cells have NOT invaded blood vessels or lymph vessels
• Invasion into these vessels increases the risk of spread; your absence of this is favorable

No Neurotropism (Perineural Invasion)

• This means the melanoma has NOT grown into or around nerves
• Nerve invasion is associated with higher recurrence risk; you don't have this

Scant Tumor-Infiltrating Lymphocytes (TILs)

• Your immune system's response to the tumor is minimal ("scant")
• While some TILs can be protective, this finding is not uncommon in early-stage melanoma

---

Areas Requiring Attention

Peripheral Margin Involved by In Situ Component

This is the most important finding requiring action:

• The peripheral margin is the edge of the tissue removed during your biopsy
• In situ component means melanoma cells that are confined to the top layer of skin (epidermis) — not yet invasive
• The pathologist found these pre-cancerous cells at the edge of the biopsy specimen

What this means: The biopsy didn't remove all the abnormal cells around the tumor. You will need a wider excision surgery to remove more surrounding normal-looking skin.

According to NCCN Guidelines for Patients: Melanoma, after an initial biopsy, a wider excision is typically done even if margins appear clear. For a tumor of your thickness (0.8 mm), the recommended surgical margin is 1 to 2 cm of normal skin around the original site.

Deep Margin Less Than 1 mm from Invasive Component

• The deep margin is the base of the tissue removed (the deepest part of the biopsy)
• Your deep margin is "less than 1 mm" away from where the invasive melanoma ends
• This is still considered adequate clearance and is favorable

---

Associated Nevus (Dermal Nevus)

The report notes a "dermal nevus" — this is a benign (non-cancerous) mole found alongside your melanoma. This is not concerning and does not change your treatment plan.

---

What This Means for Your Treatment

Wide Excision Surgery

You will need a surgical procedure to remove:

1. The original biopsy site
2. A margin of normal-looking skin around it (typically 1-2 cm, depending on your tumor thickness)
3. Possibly some underlying tissue

According to NCCN Guidelines, wide excision is the primary treatment for stage 1 melanoma. The goal is to ensure all melanoma cells are removed while preserving as much normal tissue as possible.

Sentinel Lymph Node Biopsy (SLNB)

For Stage 1B melanoma, NCCN Guidelines recommend considering sentinel lymph node biopsy. This procedure:

• Uses a dye and/or radioactive tracer to identify the first lymph node(s) that drain from your melanoma site
• Removes and examines that node under a microscope to see if cancer cells have spread
• Helps determine if you need additional treatment (like immunotherapy)

SLNB is typically recommended for Stage 1B because the risk of lymph node involvement increases at this thickness, even though your other favorable features suggest lower overall risk.

---

Follow-Up and Surveillance

According to NCCN Guidelines for Patients: Melanoma, after treatment for Stage 1B melanoma, you should expect:

• Physical exams every 6 to 12 months for the first 5 years, focusing on your skin and regional lymph nodes
• Annual exams after 5 years
• Imaging tests only if you develop specific signs or symptoms (not routine screening for early-stage disease)
• Self-skin exams monthly to watch for new or changing moles

---

Why Early Detection Matters

The fact that your melanoma was caught at 0.8 mm thickness is significant. According to NCCN Guidelines, melanomas caught early — before they spread — are highly treatable. More than 3 in 4 melanomas are found early, and survival rates are excellent with appropriate treatment.

Your favorable features (no ulceration, zero mitotic rate, no vascular invasion) further improve your prognosis.

---

Questions to Ask Your Oncologist or Dermatologist

1. When should I have my wide excision surgery, and what surgical margin will you remove?
2. Do you recommend sentinel lymph node biopsy for my case, and if so, when?
3. Based on my pathology, what is my risk of recurrence, and what should I watch for?
4. What is my follow-up schedule for the next 5 years?
5. Are there any clinical trials for stage 1B melanoma that might be appropriate for me?
6. What sun protection and skin surveillance should I do at home?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.